NLRP3 and Alzheimer disease: EA pretreatment on ST36 and GV20 acupoints can prevent learning/memory dysfunction in AD-like rats, the mechanism of which may be related to the down-regulation of hippocampal NLRP3, caspase-1, IL-1β protein expression, and inhibition of microglial activation (He et al., 2020).